Other OTC - Delayed Quote USD

Medartis Holding AG (MDRSF)

84.10 +6.14 (+7.88%)
At close: May 13 at 12:33 PM EDT
Loading Chart for MDRSF
DELL
  • Previous Close 77.96
  • Open 84.10
  • Bid --
  • Ask --
  • Day's Range 84.10 - 84.10
  • 52 Week Range 77.96 - 84.10
  • Volume 113
  • Avg. Volume 1
  • Market Cap (intraday) 1.14B
  • Beta (5Y Monthly) 0.99
  • PE Ratio (TTM) 1,401.67
  • EPS (TTM) 0.06
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. It serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was founded in 1997 and is headquartered in Basel, Switzerland.

www.medartis.com

747

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MDRSF

Performance Overview: MDRSF

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MDRSF
7.88%
MSCI WORLD
9.57%

1-Year Return

MDRSF
42.54%
MSCI WORLD
23.91%

3-Year Return

MDRSF
42.54%
MSCI WORLD
0.00%

5-Year Return

MDRSF
76.13%
MSCI WORLD
43.76%

Compare To: MDRSF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MDRSF

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    1.14B

  • Enterprise Value

    1.14B

  • Trailing P/E

    1.51k

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.37

  • Price/Book (mrq)

    4.03

  • Enterprise Value/Revenue

    4.88

  • Enterprise Value/EBITDA

    40.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.29%

  • Return on Assets (ttm)

    2.11%

  • Return on Equity (ttm)

    0.25%

  • Revenue (ttm)

    212.01M

  • Net Income Avi to Common (ttm)

    619k

  • Diluted EPS (ttm)

    0.06

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    25.2M

  • Total Debt/Equity (mrq)

    10.74%

  • Levered Free Cash Flow (ttm)

    16.7M

Research Analysis: MDRSF

Company Insights: MDRSF

Research Reports: MDRSF